0 items USD 0.00Search
Your search for "delveinsight pulmonary radiation toxicity pipeline insights 2015" gave back 92 results.
CD123-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis...
Catalog:
La Merie Publishing
November 2014
Price: USD 381.00
The global respiratory care devices market is expected to reach nearly US$ 35 Billion by 2026. Respiratory care is a healthcare specialty, which is...
iGATE
September 2020
Price: USD 2,190.00
Cytokine-engineering as a measure to reduce dose-limiting toxicities of immunocytokines The development of recombinant cytokines, or mainly antibody-...
Catalog:
La Merie Publishing
January 2014
Price: USD 334.13
Lung-on-a-chip is a type of organ-on-a-chip (OoC) technology that replicates the functions of the human lung on a microfluidic chip. The lung-on-a-...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, "Innovation Tracking...
CBR Pharma Insights
June 2016
Price: USD 2,995.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are...
Catalog:
CBR Pharma Insights
June 2015
Price: USD 2,995.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
Catalog:
CBR Pharma Insights
September 2015
Price: USD 2,995.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
Catalog:
CBR Pharma Insights
July 2015
Price: USD 2,995.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
Catalog:
La Merie Publishing
May 2020
Price: USD 2,350.00
“Nonalcoholic steatohepatitis (NASH) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
Catalog:
La Merie Publishing
March 2015
Price: USD 2,183.00
